Pure Global

Sirolimus Coated Balloon Catheter - India CDSCO Medical Device Registration

Sirolimus Coated Balloon Catheter is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID G/28/1396_5410914391313a4558766d6188e5cd6f_b8be908a0963bc722c41da9c0cf7193e. This device is marketed under the brand name Devoir, Vanquisher. The license holder is Envision Scientific Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Sirolimus Coated Balloon Catheter
UID: G/28/1396_5410914391313a4558766d6188e5cd6f_b8be908a0963bc722c41da9c0cf7193e

Brand Name

Devoir, Vanquisher

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

Sirolimus Coated Balloon Catheter is intended for use in the treatment of patients with clinical symptoms of myocardial ischemia related to the pathological condition of one or more coronary arteries. Sirolimus Coated Balloon Catheter is therefore indicated to dilate the diseased segment(Devoir, Vanquisher) and deliver drug in a coronary artery or a graft, to improve myocardial perfusion with balloon lengths ranging from 10.00 to 40.00 mm and diameters ranging from 1.50 mm to 4.00 mm to treat lesion length from 8.00 mm to 38.00 mm. The device is intended for use in following conditions: Patients with Inโ€stent restenosis of previous stent implantation. Patients with disease in small vessels where Drug eluting stent implantation is either not feasible or involving higher risk of restenosis. Patients with bifurcation lesions, where side branch stent treatment increases risks of dissection, restenosis and a balloon catheter treatment is more advised

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing